Sensei Biotherapeutics Aktie
WKN DE: A2QM6J / ISIN: US81728A1088
17.10.2025 20:35:31
|
Sensei Biotherapeutics Shares Drop 34% On Phase 1/2 Trial Data Of Solnerstotug
(RTTNews) - Sensei Biotherapeutics, Inc. (SNSE) shares fell 33.29 percent to $11.73, down $5.85 on Friday after reporting results from the dose expansion portion of its Phase 1/2 trial evaluating solnerstotug, a conditionally active monoclonal antibody targeting VISTA. The data were presented at the ESMO Congress 2025.
The stock traded between $10.52 and $17.50 during the session, compared with a previous close of $17.58 on the Nasdaq. Volume reached 744,100 shares, well above the average of 18,937.
The 52-week range is between $5.00 and $18.35.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sensei Biotherapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |